• Home
  • Study Details
Not currently enrolling

COVID Antiviral Pediatric Study

The purpose of this study is to learn more about the safety and effectiveness of an oral antiviral treatment for children with COVID infection who are at risk of severe disease.

Age & Gender

  • 0 months ~ 17 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Michelle Hernandez
Pediatrics - Children's Research Institute

Study Type

Clinical or Medical
Interventional

Study Topics

Child and Teen Health
Immune System/Infections
Parents of Children
COVID-19

IRB Number

22-0400

ClinicalTrials.gov

Not yet available

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research